文献速递肝病

EncephalApp Stroop试验联合NCT-B和SDT评分准确识别隐匿性肝性脑病

Combined Scores from the EncephalApp Stroop Test, Number Connection Test B, and Serial Dotting Test Accurately Identify Patients With Covert Hepatic Encephalopathy.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-11-09

该研究在上海9个社区569名成人志愿者中确定EncephalApp Stroop试验评分范围,并以标准PHES为参考标准,开发联合EncephalApp Stroop、NCT-B和SDT的新策略诊断CHE,并在中国5个中心160例肝硬化患者中验证;联合评分诊断CHE的AUC为0.86,敏感度81.0%,特异度91.9%,准确率87.5%,验证队列AUC为0.88,准确率86.9%,计算时间短于完整PHES。

要点

  • EncephalApp Stroop联合NCT-B和SDT可准确识别CHE,准确率约87%。
  • 联合评分计算时间374±140秒,短于完整PHES的424±115秒。
  • 年龄、教育水平和性别与EncephalApp Stroop评分独立相关。

核心结论

  • EncephalApp Stroop试验、NCT-B和SDT联合评分识别CHE的准确率约87%,可作为有效便捷的方法。

研究设计与样本

  • 研究在上海9个社区调查569名成人志愿者(229名男性)以确定EncephalApp Stroop评分范围,并以标准PHES为参考标准开发CHE诊断新策略。
  • 研究在中国5个中心160例肝硬化患者中验证联合评分策略。

主要发现

  • EncephalApp Stroop评分范围按年龄、教育水平和性别分层确定,年龄、教育水平和性别与评分独立相关。
  • 联合EncephalApp Stroop评分187秒和NCT-B低于-1或SDT低于-1诊断CHE的AUC为0.86,敏感度81.0%,特异度91.9%,准确率87.5%。
  • 验证队列中相同截断值诊断CHE的AUC为0.88,敏感度97.1%,特异度79.3%,准确率86.9%。
  • 联合评分平均计算时间374±140秒,完整PHES为424±115秒。

关键数值与推荐

  • 联合评分截断值:EncephalApp Stroop评分187秒且NCT-B低于-1或SDT低于-1。
  • 开发队列诊断CHE的AUC 0.86,敏感度81.0%,特异度91.9%,准确率87.5%。
  • 验证队列诊断CHE的AUC 0.88,敏感度97.1%,特异度79.3%,准确率86.9%。

临床怎么用

  • 联合EncephalApp Stroop、NCT-B和SDT评分可用于识别CHE,较完整PHES更省时。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The EncephalApp Stroop test is a high-sensitivity but low-specificity test that has been used to identify patients with covert hepatic encephalopathy (CHE). We aimed to develop a new strategy to detect CHE, combining EncephalApp Stroop test score with scores from subtests of the psychometric hepatic encephalopathy scoring system (PHES). METHODS: We performed a survey of 569 adult volunteers (229 men) in 9 communities in Shanghai, China, administering the EncephalApp Stroop test to determine the range of scores in the general population. Data from the standard PHES, including the number connection test-A, number connection test-B (NCT-B), line tracing test, serial dotting test (SDT), and digit symbol test, were used as the reference standard for diagnosis of CHE. A combination of the EncephalApp Stroop with subtests of the PHES was used to establish a new strategy for CHE diagnosis. We validated our findings using data from 160 patients with cirrhosis from 5 centers China. RESULTS: We determined the range of EncephalApp Stroop test scores for the volunteers of different decades of age, education levels, and sexes. Age, education level, and sex were independently associated with EncephalApp Stroop test scores. A combination of scores from the EncephalApp Stroop test, the NCT-B, and the SDT identified patients with CHE with the highest level of accuracy, when the standard PHES was used as the reference standard. A combination of scores of 187 sec for the EncephalApp Stroop test and below -1 for the NCT-B or below -1 for the SDT identified patients with CHE with an area under the curve (AUC) of 0.86, 81.0% sensitivity, and 91.9% specificity, and 87.5% accuracy. In the validation cohort, these cutoff scores identified patients with CHE with an AUC of 0.88, 97.1% sensitivity, 79.3% specificity, and 86.9% accuracy. The average time to calculate this score was 374±140 sec, compared 424±115 sec for the entire PHES. CONCLUSION: Scores from the EncephalApp Stroop test, NCT-B, and SDT identify patients with CHE with approximately 87% accuracy, and in a much shorter time than the standard PHES. This score combination could be a valid and convenient method for identifying patients with CHE. chictr.org.cn number, ChiCTR-EDC-17012007, ChiCTR1800019954.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Zeng X, Zhang LY, Liu Q, et al. Combined Scores from the EncephalApp Stroop Test, Number Connection Test B, and Serial Dotting Test Accurately Identify Patients With Covert Hepatic Encephalopathy. Clin Gastroenterol Hepatol. 2019. PMID: 31712074. doi:10.1016/j.cgh.2019.11.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。